Latin America & the Caribbean (IDA & IBRD countries) | Antiretroviral therapy coverage (% of people living with HIV)

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy. Limitations and exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information. Statistical concept and methodology: Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. Antiretroviral therapy has led to huge reductions in death and suffering of people with advanced HIV infection.
Publisher
The World Bank
Origin
Latin America & the Caribbean (IDA & IBRD countries)
Records
63
Source
Latin America & the Caribbean (IDA & IBRD countries) | Antiretroviral therapy coverage (% of people living with HIV)
year value
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000 10.62982005
2001 12.9266078
2002 15.56319483
2003 18.71894094
2004 20.70853474
2005 23.5597272
2006 27.13967996
2007 30.46606335
2008 32.76283619
2009 35.88093068
2010 38.28737249
2011 41.03014677
2012 44.53500303
2013 46.71205024
2014 49.20491383
2015 52.74616763
2016 55.79558467
2017 57.80585131
2018 59.4937699
2019 63.2258036
2020 66.97068766
2021 69.76587634
2022

Latin America & the Caribbean (IDA & IBRD countries) | Antiretroviral therapy coverage (% of people living with HIV)

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy. Limitations and exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information. Statistical concept and methodology: Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. Antiretroviral therapy has led to huge reductions in death and suffering of people with advanced HIV infection.
Publisher
The World Bank
Origin
Latin America & the Caribbean (IDA & IBRD countries)
Records
63
Source